choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • AtriCure Clinical Trials

AtriCure Clinical Trials Newsletter
  • AtriCure completes enrollment in stroke prevention trial 16 Jul 2025 00:46 GMT

    … AtriClip system. [Image courtesy of AtriCure] AtriCure (Nasdaq: ATRC) + today announced … clinical evidence initiative that demonstrates AtriCure’s unwavering commitment to … to the exceptional team of clinical trial investigators and broader clinician …

  • AtriCure, Inc. (ATRC) Q4 2024 Earnings Call Transcript 13 Feb 2025 04:37 GMT

    … the potential market opportunity for AtriCure's franchises and … clearances, competition, reimbursement and clinical trial outcomes. AtriCure's results may differ … materially from those projected. AtriCure undertakes no obligation to publicly …

  • AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results 12 Feb 2025 21:21 GMT

    … related to new product introductions, clinical trials and acquired IPR&D … days following the presentation. About AtriCure AtriCure, Inc. provides innovative technologies … GAAP Financial Measures To supplement AtriCure’s condensed consolidated financial …

  • AtriCure leadership explains $45M investment in Greater Cincinnati HQ 19 Aug 2024 11:12 GMT

    … low-cost environments.” Alternatively, AtriCure (Nasdaq: ATRC) might … local high schools. AtriCure is the largest employer … from,” he said. AtriCure focuses on cardiovascular conditions … company started the largest clinical trial ever done in cardiovascular …

  • AtriCure, Inc. (NASDAQ:ATRC) Q2 2024 Earnings Call Transcript 31 Jul 2024 12:48 GMT

    … clearances, competition, reimbursement and clinical trial outcomes. AtriCure’s results may differ materially … . This landmark and global clinical trial is expected to show a … in our LeAAPS clinical trial and resources focused on both clinical trials and new …

  • AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript 02 May 2024 19:48 GMT

    … approvals, clearances, reimbursement and clinical trial outcomes. AtriCure’s results may differ … . If successful, this massive clinical trial along with existing robust clinical … devices. Enrollment in the LeAAPS clinical trial has continued rapidly, with …

  • AtriCure Announces the First Patient Treated in the LeAAPS™ Clinical Trial 31 Jan 2023 13:10 GMT

    … , investigational device exemption (IDE) clinical trial to evaluate the safety and … atrial fibrillation and stroke.” About AtriCure AtriCure, Inc. provides innovative technologies … of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation …

  • AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript 16 Feb 2024 16:37 GMT

    … approvals, clearances, reimbursement and clinical trial outcomes. AtriCure’s results may differ materially … Afib diagnosis through our LeAAPS clinical trial. The LeAAPS trial seeks … and expansion of our LeAAPS clinical trial and multiple product development …

  • AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results 15 Feb 2024 21:10 GMT

    … driven by investments in clinical trials and product development initiatives outpacing … following the presentation. About AtriCure AtriCure, Inc. provides innovative technologies … Financial Measures To supplement AtriCure’s condensed consolidated financial …

  • AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial 07 Jun 2022 12:33 GMT

    AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that the first patient was treated in the …

Satisfied with the content?

Continue to create your account.